Boothbay Fund Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.7K | Hold |
20,900
| – | – | ﹤0.01% | 1118 |
|
|
2025
Q1 | $102K | Hold |
20,900
| – | – | ﹤0.01% | 1060 |
|
|
2024
Q4 | $140K | Buy |
20,900
+1
| +0% | +$7 | ﹤0.01% | 1082 |
|
|
2024
Q3 | $162K | Buy |
20,899
+5,850
| +39% | +$45.2K | ﹤0.01% | 1223 |
|
|
2024
Q2 | $90.3K | Hold |
15,049
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q1 | $136K | Buy |
15,049
+1,561
| +12% | +$14.1K | ﹤0.01% | 1213 |
|
|
2023
Q4 | $128K | Hold |
13,488
| – | – | ﹤0.01% | 1237 |
|
|
2023
Q3 | $161K | Buy |
13,488
+1,179
| +10% | +$14K | ﹤0.01% | 1277 |
|
|
2023
Q2 | $302K | Hold |
12,309
| – | – | 0.01% | 1097 |
|
|
2023
Q1 | $385K | Buy |
12,309
+4,332
| +54% | +$136K | 0.01% | 1168 |
|
|
2022
Q4 | $562K | Sell |
7,977
-387
| -5% | -$27.2K | 0.01% | 936 |
|
|
2022
Q3 | $720K | Sell |
8,364
-7,810
| -48% | -$672K | 0.02% | 920 |
|
|
2022
Q2 | $1.34M | Buy |
16,174
+4,869
| +43% | +$403K | 0.04% | 623 |
|
|
2022
Q1 | $1.88M | Hold |
11,305
| – | – | 0.04% | 502 |
|
|
2021
Q4 | $1.89M | Buy |
+11,305
| New | +$1.89M | 0.04% | 418 |
|